Polyelectrolyte membranes derived from soluble perfluorocyclobutane polymers with sulfonyl chloride groups

Information

  • Patent Grant
  • 7989512
  • Patent Number
    7,989,512
  • Date Filed
    Wednesday, March 17, 2010
    14 years ago
  • Date Issued
    Tuesday, August 2, 2011
    13 years ago
Abstract
A method of forming an ionomeric membrane includes a step of reacting a first polymer in chlorosulfonic acid to form a first precipitate. The first precipitate comprising a polymer including a polymer unit having at least one —SO2Cl moiety attached thereto and includes a step of dissolving the first precipitate in a polar aprotic solvent to form the first solution. A polymeric membrane is then formed from the first solution such that the membrane includes the polymer unit having at least one —SO2Cl. The polymer including a polymer unit a polymer unit having at least one —SO2Cl is then reacted with a nucleophilic compound to form the polymeric membrane.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention


The present invention relates to ion conductive polymers, fuel cell membranes and membrane electrode assemblies.


2. Background Art


Proton conductive polymer membranes are an important component in a fuel cell device. To achieve optimal fuel cell performance, the proton conductive polymer membrane must maintain a high ionic conductivity and mechanical stability at high and low relative humidity. Aromatic perfluorocyclobutane random copolymers have been disclosed in U.S. Pat. No. 6,559,237 as improved membrane materials for fuel cells. Due to the chain configuration of random copolymers, however, water swelling at high humidity and membrane shrinking at low humidity are common problems with random copolymers. A random copolymer membrane lacks the mechanical robustness to withstand the rigors of hydration and dehydration within an operating fuel cell.


Accordingly, there is a need to provide a further improved proton conductive polymer membrane that maintains robust mechanical properties and high ionic conductivity at a wide range of humidity conditions.


SUMMARY OF THE INVENTION

The present invention solves one or more problems of the prior art by providing in at least one embodiment a method of forming an ionomeric membrane. The ionomeric membrane comprises a polymer unit having formula 1:




embedded image



wherein:


P1, P2, are each independently absent, —O—, —S—, —SO—, —SO2—, —CO—, —NH—, —NR2—, or —R3—;


R1 is —OR5, —NRS, —X, —NHR5Z2, or —OR5Z2, —NHSO2CF3;


R2 is C1-25 alkyl or C1-25 aryl;


R3 is C1-25 alkylene, C1-25 perfluoroalkylene, or C1-25 arylene;


R4 is trifluoromethyl, C1-25 alkyl, C1-25 perfluoroalkylene, C1-25 aryl, or another E1 group;


R5 is C1-25 alkyl or C1-25 aryl;


E1 is an aromatic-containing moiety;


Z2 is —SO3H, —PO3H, —OH, or —NH2;


X is an —OH, a halogen, an ester,




embedded image


i is an integer from 1 to 10,000; and


Q1 is a fluorinated cyclobutyl moiety, the method comprising:


a) reacting a polymer comprising a polymer unit having formula 3 in chlorosulfonic acid to form a first precipitate, the first precipitate comprising a polymer comprising a polymer unit having formula 4 and dissolves in a polar aprotic solvent to form a first solution:




embedded image




embedded image


b) forming a polymeric membrane from the first solution, the polymeric membrane including the polymer comprising a polymer unit having formula 4; and


c) reacting the polymer comprising a polymer unit having formula 4 with a nucleophilic compound to form the base polymer having polymer unit 1.


It should be understood that the detailed description and specific examples, while disclosing exemplary embodiments of the invention, are intended for purposes of illustration only and are not intended to limit the scope of the invention.





BRIEF DESCRIPTION OF THE DRAWINGS

Exemplary embodiments of the present invention will become more fully understood from the detailed description and the accompanying drawings, wherein:



FIG. 1 provides a schematic illustration of a fuel cell incorporating the polymers of an embodiment of the present invention;



FIG. 2 is a reaction scheme describing the synthesis of examples of preferred embodiments of the invention.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT(S)

Reference will now be made in detail to presently preferred compositions, embodiments and methods of the present invention, which constitute the best modes of practicing the invention presently known to the inventors. The Figures are not necessarily to scale. However, it is to be understood that the disclosed embodiments are merely exemplary of the invention that may be embodied in various and alternative forms. Therefore, specific details disclosed herein are not to be interpreted as limiting, but merely as a representative basis for any aspect of the invention and/or as a representative basis for teaching one skilled in the art to variously employ the present invention.


Except in the examples, or where otherwise expressly indicated, all numerical quantities in this description indicating amounts of material or conditions of reaction and/or use are to be understood as modified by the word “about” in describing the broadest scope of the invention. Practice within the numerical limits stated is generally preferred. Also, unless expressly stated to the contrary: percent, “parts of,” and ratio values are by weight; the term “polymer” includes “oligomer,” “copolymer,” “terpolymer,” “block”, “random,” “segmented block,” and the like; the description of a group or class of materials as suitable or preferred for a given purpose in connection with the invention implies that mixtures of any two or more of the members of the group or class are equally suitable or preferred; description of constituents in chemical terms refers to the constituents at the time of addition to any combination specified in the description, and does not necessarily preclude chemical interactions among the constituents of a mixture once mixed; the first definition of an acronym or other abbreviation applies to all subsequent uses herein of the same abbreviation and applies mutatis mutandis to normal grammatical variations of the initially defined abbreviation; and, unless expressly stated to the contrary, measurement of a property is determined by the same technique as previously or later referenced for the same property.


It is also to be understood that this invention is not limited to the specific embodiments and methods described below, as specific components and/or conditions may, of course, vary. Furthermore, the terminology used herein is used only for the purpose of describing particular embodiments of the present invention and is not intended to be limiting in any way.


It must also be noted that, as used in the specification and the appended claims, the singular form “a,” “an,” and “the” comprise plural referents unless the context clearly indicates otherwise. For example, reference to a component in the singular is intended to comprise a plurality of components.


Throughout this application, where publications are referenced, the disclosures of these publications in their entireties are hereby incorporated by reference into this application to more fully describe the state of the art to which this invention pertains.


The following description of the embodiment(s) is merely exemplary in nature and is in no way intended to limit the invention, its application, or uses.


The term “block” as used herein means a portion of a macromolecule, comprising many constitutional units, that has at least one feature that is not present in adjacent portions.


The term “block macromolecule” as used herein means a macromolecule that is composed of blocks in linear sequence.


The term “block polymer” as used herein means a substance composed of block macromolecules.


The term “block copolymer” as used herein means a polymer in which adjacent blocks are constitutionally different, i.e., each of these blocks comprises constitutional units derived from different characteristic species of monomer or with different composition or sequence distribution of constitutional units.


The term “random copolymer” as used herein means a copolymer consisting of macromolecules in which the probability of finding a given repeating unit at any given site in the chain is independent of the nature of the adjacent units.


With reference to FIG. 1, a fuel cell that incorporates a polymer electrolyte including polymers from the invention is provided. PEM fuel cell 10 includes polymeric ion conductive membrane 12 disposed between cathode catalyst layer 14 and anode catalyst layer 16. Polymeric ion conductive composite membrane 12 includes one or more of the polymers set forth below. Fuel cell 10 also includes conductive plates 20, 22, gas channels 60 and 66, and gas diffusion layers 24 and 26. Advantageously, the present invention provides embodiments for composite membrane 12.


In an embodiment of the present invention, a method of forming an ionomeric membrane is provided. The ionomeric membrane comprises a polymer unit having formula 1:




embedded image



wherein:


P1, P2, are each independently absent, —O—, —S—, —SO—, —SO2—, —CO—, —NH—, —NR2—, or —R3—;


R1 is —OR5, —NRS, —X, —NHR5Z2, or —OR5Z2, —NHSO2CF3;


R2 is C1-25 alkyl or C1-25 aryl;


R3 is C1-25 alkylene, C1-25 perfluoroalkylene, or C1-25 arylene;


R4 is trifluoromethyl, C1-25 alkyl, C1-25 perfluoroalkylene, C1-25 aryl, or another E1 group;


R5 is C1-25 alkyl or C1-25 aryl;


i is an integer;


E1 is an aromatic-containing moiety;


Z2 is —SO3H, —PO3H, —OH, or —NH2;


X is an —OH, a halogen, an ester,




embedded image


i is an integer from 1 to 10,000; and


Q1 is a fluorinated cyclobutyl moiety.


With reference to FIG. 2, reaction scheme for forming the polymer unit having formula 1 are provided. In step a) of the method, a polymer comprising a polymer unit having formula 3 is dissolved in dichloromethane and reacted with chlorosulfonic acid and the corresponding arylsulfonyl chloride is dissolved in a polar aprotic solvent, such as N,N′-dimethylacetamide to form a first solution. The first solution includes a polymer comprising a polymer unit having formula 4 which is at least partially dissolved in chlorosulfonic acid:




embedded image



In step b), a polymeric membrane is formed from the first solution. The polymeric membrane includes the polymer comprising a polymer unit having formula 4 which is now in the form of a membrane. In step c), the polymer comprising a polymer unit having formula 4 is reacted with a nucleophilic compound to form a base polymer having polymer unit 1.


Continuing to refer to FIG. 2, any number of nucleophic compounds are used in step c). Examples of such nucleophilic compounds include, but are not limited to, HOR5, HNR5, HX is HNHR5Z2, and HOR5Z2.


In a variation of the present embodiment, the ionomeric polymer further includes a polymer unit having formula 2:




embedded image


E2 is an aromatic-containing moiety;


P3, P4, are each independently absent, —O—, —S—, —SO—, —SO2—, —CO—, —NH—, —NR2—, or —R3—;


R2 is C1-25 alkyl or C1-25 aryl;


R3 is C1-25 alkylene, C1-25 perfluoroalkylene, or C1-25 arylene;


j is an integer from 1 to 10,000; and


Q2 is a fluorinated cyclobutyl moiety.


In a variation of the present embodiment, E1 and E2 each independently include one or more of the following moieties:




embedded image




embedded image


Examples for Q1 and Q2 in the above formulae are:




embedded image


The following examples illustrate the various embodiments of the present invention. Those skilled in the art will recognize many variations that are within the spirit of the present invention and scope of the claims.


Synthesis of PFCB Polymer with Sulfonyl Chloride Groups. Structure 2. In a 100-mL screw-cap jar with a magnetic stirrer, 2.5 g (42 mmol BPVE) of perfluorocyclobutane polymer TRJ-3058 [structure 5 consisting of a 2:1 ratio of BPVE oligomer (Mn=8K) copolymerized with 6F monomer, Mn=50K, Tetramer Technologies, Pendleton, S.C.] is dissolved in dichloromethane (50.0 g, >99.9%, Aldrich, cat# 439233). Chlorosulfonic acid (6.25 g, 2.5 wt eq., 12.8 mol. eq.) is added and the reaction mixture is stirred mechanically while maintaining an internal reaction temperature of 36° C. After 15-20 minutes a purple chlorosulfonated-PFCB polymer precipitates out of solution and then after 1 hour, the supernatant dichloromethane is decanted off. The collected precipitate is blended and washed thoroughly with methylene chloride and then filtered. The collected polymer with sulfonyl chloride groups (and having the structure 6) is then dried under vacuum at 25° C. for 16 hrs. This polymer dissolves in N,N-dimethylacetamide.




embedded image



Nucleophilic Substitution of Structure 5 Sulfonyl Chloride Groups to Form Polymer 3.


To a 250-mL round-bottom flask is added CF3SO2NNaSi(CH3)3 [3.71 g, 15.3 mmol, made as described in Thomas, B. H., G. Shafer, J. J. Ma, M.-H. Tu, D. D. DesMarteau, J. Fluorine Chem., 125 (2004)1231-1240], N,N-dimethylacetamide (DMAc) (100 mL) and polymer 6 (3.8 grams, 7.6 mmol SO2Cl). The reaction mixture is stirred at 80° C. under nitrogen for 2 days. The resultant solution is added to 2 M sulfuric acid (1 L) to precipitate a polymer that is filtered and vacuum dried. The polymer is then coated from a 10 wt. % solids solution in DMAc onto windowpane glass, and the wet film is then heated at 80° C. until dry. The film is floated off of the glass by immersion in water and then is air dried.




embedded image


A 10 wt % solution is prepared by dissolving 1.0 g of the sulfonamide polymer in 9.0 grams of N,N-dimethylacetamide (>99.9%, Aldrich, cat# 270555) at 50° C. over a period of 2 hours. The solution is homogenized at 15,000 rpm for a few minutes.


Preparation of KF-2751 Elastomer Solution


A 10 wt % solution of Kynar® vinylidene fluoride resin, grade 2751-00 (Arkema, Lot#03C8106) is prepared by dissolving 20 g of the elastomer powder in 180 grams of N,N-dimethylacetamide (>99.9%, Aldrich, cat# 270555) by rolling in a jar at room temperature overnight.


Preparation of Blend Solution


An ionomer/elastomer blended solution is prepared by mixing 7 g of a 10 wt % N,N-dimethylacetamide solution of polymer 7 with 3 g of a 10 wt % solution of KF-2751 in N,N-dimethylacetamide and homogenizing at 20,000 RPM twice for 3 minute intervals to yield clear yellow solutions. The solution is filtered through a 5 micron Mitex™ membrane PTFE filters using high pressure directly into centrifuge tubes. The tubes are capped and spun for 10 minutes at 3,000 rpm to remove air bubbles.


Membrane Coating


A sheet of window pane glass is placed on the vacuum table on an Erichson casting table with platen set at 80° C. The surface is wiped clean with iso-propanol and the ionomer solution is coated at a blade gap of 10 mil at a draw speed of 12.5 mm/s at 50° C. Drying is continued at 80° C. for 20 minutes and the membranes are cut away in 10 cm×10 cm sections for characterization.


A sheet of window pane glass is placed on the vacuum table on an Erichson casting table with platen set at 80° C. The surface is wiped clean with iso-propanol and the ionomer solution is coated at a blade gap of 10 mil at a draw speed of 12.5 mm/s at 50° C. Drying is continued at 80° C. for 20 minutes and the membranes are cut away in 10 cm×10 cm sections for characterization.


While embodiments of the invention have been illustrated and described, it is not intended that these embodiments illustrate and describe all possible forms of the invention. Rather, the words used in the specification are words of description rather than limitation, and it is understood that various changes may be made without departing from the spirit and scope of the invention.

Claims
  • 1. A method of forming an ionomeric membrane comprising a polymer unit having formula 1:
  • 2. The method of claim 1 wherein the nucleophilic compound is HOR5.
  • 3. The method of claim 1 wherein the nucleophilic compound is HNR5.
  • 4. The method of claim 1 wherein the nucleophilic compound is HX.
  • 5. The method of claim 1 wherein the nucleophilic compound is HNHR5Z2.
  • 6. The method of claim 1 wherein the nucleophilic compound is HOR5Z2.
  • 7. The method of claim 1 wherein the base polymer further includes a polymer unit having formula 2:
  • 8. The method of claim 7 wherein E1 and E2, independently include one or more of the following moieties:
  • 9. The method of claim 1 wherein Z2 is —SO3H.
  • 10. A fuel cell comprising the ionomeric membrane of claim 1.
  • 11. A method of forming an ionomeric membrane comprising polymer units having formulae 1 and 2:
  • 12. The method of claim 11 wherein the nucleophilic compound is HOR5.
  • 13. The method of claim 11 wherein the nucleophilic compound is HNR5.
  • 14. The method of claim 11 wherein the nucleophilic compound is HX.
  • 15. The method of claim 11 wherein the nucleophilic compound is HNHR5Z2.
  • 16. The method of claim 11 wherein the nucleophilic compound is HOR5Z2.
  • 17. The method of claim 11 wherein E1 and E2, independently include one or more of the following moieties:
  • 18. The method of claim 11 wherein Z2 is —SO3H.
  • 19. A fuel cell comprising the ionomeric membrane of claim 1.
  • 20. A method of forming an ionomeric membrane comprising polymer unit having formulae 1 and 2:
US Referenced Citations (55)
Number Name Date Kind
5006408 Green et al. Apr 1991 A
5021602 Clement et al. Jun 1991 A
5037917 Babb et al. Aug 1991 A
5066746 Clement et al. Nov 1991 A
5159037 Clement et al. Oct 1992 A
5159038 Babb et al. Oct 1992 A
5910378 Debe et al. Jun 1999 A
6124060 Akita et al. Sep 2000 A
6183668 Debe et al. Feb 2001 B1
6277512 Hamrock et al. Aug 2001 B1
6444343 Prakash et al. Sep 2002 B1
6523699 Akita et al. Feb 2003 B1
6559237 Mao et al. May 2003 B1
6847518 Fukuda et al. Jan 2005 B2
6875537 Tani et al. Apr 2005 B2
6926984 Asano et al. Aug 2005 B2
6933068 Asano et al. Aug 2005 B2
6953653 Smith et al. Oct 2005 B2
6986962 Oyanagi et al. Jan 2006 B2
7001929 Goto et al. Feb 2006 B2
7045241 Akita et al. May 2006 B2
20010018144 Watakabe et al. Aug 2001 A1
20020014405 Arcella et al. Feb 2002 A1
20030017379 Menashi Jan 2003 A1
20040214058 Tada et al. Oct 2004 A1
20040214065 Kanaoka et al. Oct 2004 A1
20050014927 Akita Jan 2005 A1
20050043487 Felix et al. Feb 2005 A1
20050048342 Wakahoi et al. Mar 2005 A1
20050053810 Kato et al. Mar 2005 A1
20050058864 Goebel Mar 2005 A1
20050064260 Otsuki et al. Mar 2005 A1
20050100770 Sugawara et al. May 2005 A1
20050106440 Komiya May 2005 A1
20050116206 Kakuta et al. Jun 2005 A1
20050130024 Otsuki et al. Jun 2005 A1
20050142397 Wakahoi et al. Jun 2005 A1
20050143530 Iwadate et al. Jun 2005 A1
20050175886 Fukuda et al. Aug 2005 A1
20050197467 Komiya et al. Sep 2005 A1
20050227138 Fukuda et al. Oct 2005 A1
20050233181 Wariishi et al. Oct 2005 A1
20050260474 Asano et al. Nov 2005 A1
20060019147 Fukuda et al. Jan 2006 A1
20060127728 Otsuki et al. Jun 2006 A1
20060177719 Fuller et al. Aug 2006 A1
20070042242 Tada et al. Feb 2007 A1
20070099054 Fuller et al. May 2007 A1
20070141237 Okiyama et al. Jun 2007 A1
20080027152 Maier et al. Jan 2008 A1
20090278083 Fuller et al. Nov 2009 A1
20090278091 MacKinnon et al. Nov 2009 A1
20090281245 MacKinnon et al. Nov 2009 A1
20090281262 MacKinnon et al. Nov 2009 A1
20090281270 Fuller et al. Nov 2009 A1
Foreign Referenced Citations (7)
Number Date Country
2003535929 Dec 2003 JP
2005129298 May 2005 JP
2005166557 Jun 2005 JP
2005179380 Jul 2005 JP
2009 249 487 Oct 2009 JP
2004051776 Jun 2004 WO
2007052954 May 2007 WO